What to Expect From Telehealth Ketamine Therapy

Starting any new medical treatment comes with questions, uncertainty, and sometimes anxiety. Telehealth ketamine therapy is no different—and for many people, the novelty of receiving a psychoactive controlled substance at home through an online provider makes the unknown feel even larger. This guide walks you through every phase of the process so you know exactly what to expect before you begin.

Phase 1: Initial Inquiry and Intake

Most telehealth ketamine platforms begin with an online intake form or screening questionnaire. This is your first step and typically takes 15-30 minutes to complete. You will be asked about:

• Your primary diagnosis or reason for seeking treatment (depression, anxiety, PTSD, chronic pain, etc.)
• Your psychiatric history, including previous diagnoses and hospitalizations
• Your medical history, including cardiovascular health, kidney and liver function, and neurological conditions
• Current medications, including supplements
• Substance use history
• Any prior ketamine or psychedelic experience

This intake serves two purposes: it helps the platform determine whether you are likely a candidate before you invest time in a full evaluation, and it gives the provider a detailed clinical picture to review before your first appointment.

What Happens if You Don't Meet Criteria

If your intake reveals exclusion criteria—such as active psychosis, uncontrolled hypertension, or a history of ketamine misuse—you will typically be notified and offered a referral to an in-person provider better suited to your needs. Reputable platforms do not accept every applicant, and that selectivity is a sign of good clinical practice. For more on who qualifies, see our guide on patient selection criteria.

Phase 2: The Medical Evaluation

Your first video appointment with a licensed provider is the core of the evaluation process. Expect this appointment to last between 45 and 75 minutes. A good evaluation includes:

Clinical Interview

The provider will review your intake questionnaire with you and ask follow-up questions. They want to understand the severity and duration of your symptoms, what treatments you have already tried, and your overall clinical picture. They may administer validated symptom scales (like the PHQ-9 for depression or the PCL-5 for PTSD) to establish a baseline.

Informed Consent

The provider will explain how ketamine works, the difference between what is known from clinical research and what remains uncertain, the risks involved, what the at-home experience will be like, and what the monitoring plan includes. You will sign an informed consent document—this is a legal and ethical requirement, not a formality.

Questions and Expectations Setting

This is your opportunity to ask everything. Good providers encourage questions about dosing, what the psychedelic experience might feel like, what to do if you feel frightened during a session, and how progress will be tracked.

Phase 3: Prescription and Medication Delivery

If the provider determines you are a candidate, they issue a prescription—most commonly for compounded sublingual ketamine troches. The prescription goes directly to a compounding pharmacy licensed to dispense in your state. Shipping typically takes 5-10 business days.

You will receive the medication with detailed instructions on dosing, storage, and handling. Sublingual troches are held under the tongue for a specified period (usually 10-15 minutes), then spit out. Swallowed ketamine has significantly lower bioavailability, so proper technique matters.

Phase 4: Preparation for Your First Session

Before your first session, most platforms provide a preparation guide and sometimes a pre-session coaching call. Preparation typically includes:

• Fasting: Eating a light meal or fasting for 4-6 hours before the session reduces nausea.
• Environment setup: Creating a quiet, comfortable space where you will not be disturbed. Dimmed lighting, comfortable bedding, an eye mask, and curated music (many platforms provide playlists) are standard recommendations. Our set and setting guide covers environment preparation in depth.
• Having a sitter: Most responsible platforms require or strongly recommend that a sober adult be present during your session, particularly the first one. This person is not a medical professional—they are present for safety and grounding.
• Device setup: Your device for video monitoring should be charged and positioned so the provider or care guide can see you throughout the session.
• Setting an intention: Many programs encourage patients to reflect on what they hope to explore or address during the session. This psychological preparation is associated with better outcomes.

Phase 5: The Session Experience

Onset and Peak

After taking the sublingual dose, onset typically begins within 15-30 minutes. You may notice tingling, light-headedness, a sense of dissociation, and perceptual changes. At therapeutic doses, these effects are noticeable but manageable for most patients. At the peak (roughly 30-60 minutes after dosing), you may experience significant alterations in perception of time, space, and self.

What the Experience Feels Like

Patients commonly describe feelings of floating, visual patterns with eyes closed, a sense of detachment from the body, and sometimes profound emotional experiences. Some describe moments of deep peace; others encounter difficult emotions or memories. The experience is not always comfortable, but most patients find it meaningful.

Returning to Baseline

Effects typically diminish over 60-90 minutes. You will feel groggy and cognitively impaired for 1-2 hours after a session ends. You should not drive, operate machinery, or make important decisions for the remainder of the day.

Phase 6: Post-Session Integration

The hours and days after a ketamine session are considered the "integration window"—a period when the insights and emotional material from the session can be consciously processed and woven into daily life. Most telehealth platforms offer:

• Same-day check-in: A brief call or secure message with a care guide to assess how you are feeling.
• Integration exercises: Journaling prompts, reflection guides, or meditation practices specifically designed for post-ketamine integration.
• Therapist access: Some platforms include integration therapy sessions; others recommend working with an outside therapist.

Phase 7: Ongoing Treatment and Follow-Up

Most telehealth ketamine programs involve a series of sessions over several weeks—commonly 6 sessions over 3-6 weeks for the initial course. After completing the initial series, your provider will evaluate your response and discuss whether maintenance sessions are appropriate.

Follow-up video appointments are scheduled at regular intervals (often monthly) to review symptom scores, discuss any concerns, and adjust the treatment plan. Good programs track your progress systematically and do not simply re-prescribe indefinitely without re-evaluation. Learn more in our article on follow-up care in telehealth ketamine programs.

What Good Progress Looks Like

Patients who respond well typically notice improvements in mood, motivation, sleep, or emotional flexibility within days to weeks of beginning treatment. Some describe the experience as a "reset"—a brief window of neurological plasticity during which new patterns of thought and behavior become more accessible. This is why integration—the psychological work done after sessions—is as important as the sessions themselves.

References

• StatPearls: Ketamine — Comprehensive clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
• PubChem: Ketamine Compound Summary — NCBI chemical database entry with ketamine molecular data, pharmacokinetics, and bioactivity profiles
• MedlinePlus: Ketamine — National Library of Medicine consumer drug information on ketamine including uses, proper administration, and precautions
• NIMH: Anxiety Disorders — National Institute of Mental Health information on anxiety disorder types, symptoms, and evidence-based treatments
• HHS: Telehealth — U.S. Department of Health and Human Services guide to telehealth services, regulations, and patient resources